Gore Gains Coronary Stent Market Entry With Nirflex Under Medinol Pact
This article was originally published in The Gray Sheet
Executive Summary
W.L. Gore & Associates will enter the U.S. coronary stent market upon FDA approval of Medinol's Nirflex stent under a Sept. 24 worldwide stent distribution and collaboration agreement